These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 20495479
1. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U, Janzen L, Hawkins C, Taylor M, Bouffet E. J Pediatr Hematol Oncol; 2010 Jul; 32(5):e182-6. PubMed ID: 20495479 [Abstract] [Full Text] [Related]
2. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756 [Abstract] [Full Text] [Related]
3. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. Athale UH, Duckworth J, Odame I, Barr R. J Pediatr Hematol Oncol; 2009 Sep; 31(9):651-63. PubMed ID: 19707161 [Abstract] [Full Text] [Related]
11. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J. Pediatr Blood Cancer; 2007 Jul 15; 49(1):34-40. PubMed ID: 16874765 [Abstract] [Full Text] [Related]
14. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ. Pediatr Blood Cancer; 2008 May 15; 50(5):970-5. PubMed ID: 17941070 [Abstract] [Full Text] [Related]
15. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. De Amorim Bernstein K, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, MacDonald SM. Int J Radiat Oncol Biol Phys; 2013 May 01; 86(1):114-20. PubMed ID: 23498870 [Abstract] [Full Text] [Related]
16. Giant supratentorial atypical teratoid/rhabdoid tumor presentation: a case of a five-year-old child with favorable outcome and review of the literature. Sasani M, Oktenoglu T, Ozer AF, Sarioglu AC. Pediatr Neurosurg; 2007 May 01; 43(2):149-54. PubMed ID: 17337931 [Abstract] [Full Text] [Related]
17. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y. Pediatr Blood Cancer; 2004 Jul 01; 43(1):46-54. PubMed ID: 15170889 [Abstract] [Full Text] [Related]